Back to GetFilings.com



Table of Contents

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549


FORM 10-Q

(Mark One)

     
þ
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 2, 2005

OR

     
o
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from           to

Commission file number 0-30684

BOOKHAM, INC.

(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of
incorporation or organization)
  20-1303994
(I.R.S. Employer
Identification No.)
     
2584 Junction Avenue
San Jose, California

(Address of principal executive offices)
  95134
(Zip Code)

408-919-1500
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes þ No o

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of May 4, 2005, there were 33,805,437 shares of common stock outstanding.

 
 

 


BOOKHAM, INC.
TABLE OF CONTENTS

             
PART I Financial Information
 
           
  Condensed Consolidated Financial Statements     3  
  Condensed Consolidated Balance Sheets as of April 2, 2005 (Unaudited) and July 3, 2004     3  
      4  
      5  
  Notes to Condensed Consolidated Financial Statements (Unaudited)     6  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     22  
  Quantitative and Qualitative Disclosures About Market Risk     47  
  Controls and Procedures     47  
 
           
     PART II Other Information  
 
           
  Legal Proceedings     49  
  Exhibits     49  
 
        50  
 EXHIBIT 10.1
 EXHIBIT 10.2
 EXHIBIT 10.3
 EXHIBIT 10.4
 EXHIBIT 10.5
 EXHIBIT 10.6
 EXHIBIT 10.7
 EXHIBIT 10.8
 EXHIBIT 31.1
 EXHIBIT 31.2
 EXHIBIT 32.1
 EXHIBIT 32.2

2


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

BOOKHAM, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands except per share amount)
                 
    April 2, 2005     July 3, 2004  
    (Unaudited)     (A)  
Assets — Note 14
               
 
Current assets:
               
Cash and cash equivalents
  $ 27,475     $ 109,682  
Restricted cash
    3,338        
Short-term investments
    6,974       6,985  
Accounts receivable, net
    21,393       13,565  
Amounts due from related parties, net
    15,477       15,954  
Inventories
    49,393       48,339  
Prepaid expenses and other current assets
    15,471       17,887  
Assets held for resale
    14,442       13,908  
 
           
Total current assets
    153,963       226,320  
 
Long-term restricted cash
    4,265       4,434  
Goodwill
    19,977       119,953  
Other intangible assets, net
    32,568       43,849  
Property and equipment, net
    70,836       72,369  
Long-term investments
          1,100  
 
           
Total assets
  $ 281,609     $ 468,025  
 
           
 
               
Liabilities and Stockholders’ Equity
               
 
               
Current liabilities:
               
Accounts payable
  $ 32,987     $ 28,765  
Amounts owed to related parties
    532       628  
Short-term capital lease obligations
          5,131  
Accrued expenses and other liabilities
    37,579       38,351  
Current portion of loans due
    56       53  
 
           
Total current liabilities
    71,154       72,928  
 
               
Non-current portion of loans due
    379       400  
Loans due to related party
    45,860       50,000  
7% convertible note
    18,855        
Other long-term liabilities
    9,420       14,107  
 
           
Total liabilities
    145,668       137,435  
 
               
Commitments and contingencies – Note 11
               
 
               
Stockholders’ equity:
               
Common stock:
               
$0.01 par value; 175,000 shares authorized; 33,805 and 32,613 shares issued at April 2, 2005 and July 3, 2004, respectively.
    338       326  
Additional paid-in capital
    925,774       917,639  
Deferred compensation
    (1,123 )     (1,354 )
Accumulated other comprehensive income
    38,953       33,035  
Accumulated deficit
    (828,001 )     (619,056 )
 
           
Total stockholders’ equity
    135,941       330,590  
 
           
Total liabilities and stockholders’ equity
  $ 281,609     $ 468,025  
 
           


(A)   Derived from audited consolidated financial statements included in the Company’s Transition Report on Form 10-K/A for the transition period from January 1, 2004 to July 3, 2004.

The accompanying notes are an integral component of these condensed consolidated financial statements.

3


Table of Contents

BOOKHAM, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
                                 
    Three Months Ended     Nine Months Ended  
      April 2, 2005      April 4, 2004     April 2, 2005       April 4, 2004  
      (Unaudited)      (Unaudited)      (Unaudited)      (Unaudited)  
External revenues
  $ 30,684     $ 21,048     $ 80,015     $ 45,159  
Revenues from related parties
    19,255       19,918       59,239       74,242  
 
                       
Total revenues
    49,939       40,966       139,254       119,401  
 
                               
Cost of revenues
    49,392       41,760       144,352       116,853  
 
                       
 
Gross profit (loss)
    547       (794 )     (5,098 )     2,548  
 
                               
Operating expenses:
                               
Research and development
    10,648       12,451       35,071       36,353  
Selling, general and administrative
    13,957       13,426       45,595       28,480  
Amortization of other intangible assets
    2,855       2,764       8,318       6,505  
In-process research and development
          5,666             5,911  
Restructuring charges
    3,777             16,028       23,761  
Stock-based compensation expense
    289             532        
Profit on disposal of property and equipment
          (5,097 )     (650 )     (8,157 )
Goodwill impairment charge
    98,136             98,136        
 
                       
Total operating expenses
    129,662       29,210       203,030       92,853  
 
                       
 
                               
Operating loss
    (129,115 )     (30,004 )     (208,128 )     (90,305 )
 
                       
 
                               
Other income (expense):
                               
Other income (expense), net
    82             1,338       (153 )
Interest income(expense)
    (2,208 )     1,741       (2,150 )     7,308  
Gain (loss) on foreign exchange
    1,666       (3,211 )     12       (9,470 )
 
                       
Total other expense, net
    (460 )     (1,470 )     (800 )     (2,315 )
 
                               
Loss before income taxes
    (129,575 )     (31,474 )     (208,928 )     (92,620 )
 
                               
Income tax (expense) credit
                (17 )     3,439  
 
                       
 
                               
Net loss
  $ (129,575 )   $ (31,474 )   $ (208,945 )   $ (89,181 )
 
                       
 
                               
Net loss per share (basic and diluted):
  $ (3.86 )   $ (1.31 )   $ (6.27 )   $ (4.03 )
 
                       
 
Weighted average shares of common stock outstanding (basic and diluted):
    33,556       23,976       33,322       22,144  
 
                       
 
                               
Amortization of deferred stock compensation relates to the following expense categories:
                               
Cost of revenues
  $ (42 )   $     $ (24 )   $  
Research and development
    (38 )           (4 )      
Selling, general and administrative
    369             560        
 
                       
Total
  $ 289     $     $ 532     $  
 
                       

The accompanying notes are an integral component of these condensed consolidated financial statements.

4


Table of Contents

BOOKHAM, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
         
 
  Nine Months Ended
 
  April 2,   April 4,
 
  2005   2004
 
  (Unaudited)   (Unaudited)
                                 
Cash flows from operating activities:
                                 
Net loss
                  $ (208,945 )   $ (89,181 )
Adjustments to reconcile net loss to net cash used in operating activities:
                               
Depreciation of property and equipment                     15,095       7,716  
Impairment of property and equipment                     449       3,461  
Amortization of other intangible assets                     8,318       6,505  
Stock-based compensation                     532        
Write-back of acquisition expenses not incurred                     1,807        
Gain on sale of property and equipment                     (650 )     (8,157 )
Impairment of goodwill                     98,136        
Tax credit recognized for research and development activities                           (3,719 )
Foreign currency exchange rate movements on notes                     (1,316 )     (8,383 )
Amortization of interest expense for warrants and beneficial conversion feature                     231        
In-process research and development charges                           5,911  
Changes in operating assets and liabilities:                                
Accounts receivable, net
                    (7,117 )     (2,684 )
Inventories
                    117       9,016  
Prepaid expenses and other current assets
                    2,297       3,038  
Accounts payable
                    3,393       (7,710 )
Accrued expenses and other liabilities
                    (5,058 )     4,761  
 
                             
Net cash used in operating activities
                    (92,711 )     (79,426 )
 
                           
 
                               
Cash flows from investing activities:
                               
Proceeds from settlement of Westrick loan note
                    1,200        
Conversions of restricted cash
                    (1,893 )      
Purchase of property and equipment
                    (12,470 )     (9,274 )
Proceeds from sale of property and equipment
                    1,298       10,845  
Acquisitions, net of cash acquired
                          91,492  
Proceeds from disposal of subsidiaries (net of costs)
                    5,736        
 
                           
Net cash (used in) provided by investing activities
                    (6,129 )     93,063  
 
                           
 
                               
Cash flows from financing activities:
                               
Proceeds from issuance of common stock
                    3       3,262  
Proceeds from exercise of common stock warrant
                    55        
Proceeds from issuance of convertible notes and warrants to purchase common stock, net of issuance costs
                    24,175        
Repayment of capital lease obligations
                    (5,131 )     (468 )
Repayment of loans
                    (4,161 )     (49 )
 
                           
Net cash provided by financing activities
                    14,941       2,745  
 
                               
Effect of exchange rate changes on cash
                    1,692       8,198  
 
                           
Net (decrease) increase in cash and cash equivalents
                    (82,207 )     24,580  
Cash and cash equivalents at the beginning of the period
                    109,682       117,546  
 
                           
Cash and cash equivalents at the end of the period
                  $ 27,475     $ 142,126  
 
                           

The accompanying notes are an integral component of these condensed consolidated financial statements.

5


Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Nature of Business

References to “the Company” or “Bookham” mean Bookham, Inc. and its subsidiaries and refers to Bookham’s consolidated business activities since September 10, 2004 and Bookham Technology plc’s consolidated business activities prior to September 10, 2004.

Bookham is a Delaware corporation and was incorporated on June 29, 2004. On September 10, 2004, pursuant to a scheme of arrangement under U.K. law, Bookham became the publicly traded parent company of the Bookham Technology plc group of companies, including Bookham Technology plc, a public limited company incorporated under the laws of England and Wales whose stock was previously traded on the London Stock Exchange and the NASDAQ National Market. The Company’s common stock is traded on the NASDAQ National Market under the symbol “BKHM.” This Form 10-Q includes financial information for the three and nine month periods ended April 2, 2005 and compares these results with the three and nine month periods ended April 4, 2004 for the statement of operations, compares the nine months ended April 2, 2005 to the nine months ended April 4, 2004 for the statement of cash flows and compares the balance sheet at April 2, 2005 to the balance sheet at July 3, 2004.

Note 2. Basis of Preparation

The accompanying unaudited condensed consolidated financial statements as of April 2, 2005, and for the three and nine months ended April 2, 2005 and April 4, 2004, have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and include the accounts of Bookham, Inc. and all of its subsidiaries. Information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the consolidated financial position at April 2, 2005, and the consolidated operating results for the three and nine months ended April 2, 2005 and April 4, 2004, and cash flows for the nine months ended April 2, 2005 and April 4, 2004. The consolidated results of operations for the three and nine months ended April 2, 2005 are not necessarily indicative of results that may be expected for any other interim period or for the full fiscal year ending July 2, 2005.

Management makes estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and footnotes. Actual results could differ materially from those estimates. Management believes that some of the more critical accounting estimates and related assumptions that affect the Company’s financial condition and results of operations are in the areas of revenue recognition, legal contingencies, receivables, inventories, business restructuring and goodwill and other intangible assets. Estimates and assumptions are periodically reviewed and the effects of any material revisions are reflected in the period that they are determined to be necessary.

The condensed consolidated balance sheet at July 3, 2004 has been derived from the audited condensed consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. Certain comparative amounts have been reclassified to conform to current period presentations.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes included in the Company’s Transition Report on Form 10-K/A for the transition period from January 1, 2004 to July 3, 2004.

The financial statements have been prepared on a going concern basis. The Company has incurred losses and negative cash flows from operations since its inception. As of April 2, 2005 the Company had working capital of $82.8 million, and an accumulated deficit of $828.0 million. For the nine months ended April 2, 2005, the Company used $92.7 million of cash in operating activities and had a net loss of $129.6 million. The Company’s ability to meet obligations in the ordinary course of business is dependent on its ability to establish profitable operations and raise additional financing. Management believes it will be able to secure additional sources of financing in the next twelve months through the sale of assets, issuance of additional equity securities and through borrowings secured by certain properties which the Company owns. Management also intends to delay or reduce expenditures in the event additional financial resources are not available on terms acceptable to the Company. The Company’s inability to secure the necessary financing would have a material adverse affect on the Company’s financial condition and results of operations. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of assets and liabilities that may result from the outcome of this uncertainty.

6


Table of Contents

The condensed consolidated balance sheet of the Company as of July 3, 2004 and the related consolidated statements of operations for the three and nine months ended April 2, 2004 and cash flows for the nine months ended April 4, 2004 contained in this Quarterly Report on Form 10-Q have been prepared in conformity with US GAAP, or derived from audited consolidated financial statements that had been prepared in conformity with US GAAP and have been translated from pounds sterling into US Dollars using the exchange rates set forth below. Translation differences are recorded in other comprehensive income.

                 
 
  Statement of        
 
  Operations   Balance Sheet
                 
Three months ended April 4, 2004
    1.835       1.855  
Nine months ended April 4, 2004
    1.712       1.855  
As of July 3, 2004
            1.820  

Note 3. Stock-based Compensation

The Company accounts for employee stock options using the intrinsic value method in accordance with Accounting Principles Board Opinion (“APB”) No. 25, Accounting for Stock Issued to Employees, and has adopted the disclosure-only alternative of Statement of Financial Accounting Standards (“SFAS”) No. 123, Accounting for Stock-Based Compensation, as amended by SFAS No. 148, Accounting for Stock-Based Compensation—Transition and Disclosure. Under the intrinsic value method, the Company has only recorded stock-based employee compensation resulting from stock options granted at below fair market value. Stock-based compensation expense reflected in the as reported net loss includes expenses for restricted stock awards and option modifications and the amortization of certain acquisition related deferred compensation expense. No tax benefits were attributed to the stock-based employee compensation expense during the periods presented because valuation allowances were maintained on substantially all of the Company’s net deferred tax assets.

The following table illustrates the pro forma effect on net loss and loss per share if the Company had applied the fair value recognition provisions of SFAS No. 123, as amended by SFAS No. 148, to stock-based employee compensation data:

                                 
    Three months ended     Nine months ended  
    April 2, 2005     April 4, 2004     April 2, 2005     April 4, 2004  
    (in thousands, except per share data)     (in thousands, except per share data)  
Net loss as reported
  $ (129,575 )   $ (31,474 )   $ (208,945 )   $ (89,181 )
 
                               
Add: Stock-based compensation cost, included in the determination of net loss as reported
    289             532        
Deduct: Total stock-based employee compensation determined under the fair value method for all awards
    (1,048 )           (6,034 )      
 
                               
 
                       
Pro forma net loss
  $ (130,334 )   $ (31,474 )   $ (214,447 )   $ (89,181 )
 
                       
 
                               
Net loss per share:
                               
 
                               
Basic and diluted as reported
  $ (3.86 )   $ (1.31 )   $ (6.27 )   $ (4.03 )
 
                       
Basic and diluted pro forma
  $ (3.88 )   $ (1.31 )   $ (6.44 )   $ (4.03 )
 
                       

On February 9, 2005, the Company awarded restricted stock grants totaling 249,859 common shares to the Chief Executive Officer and the Chief Financial Officer (“the Participants”) under the Company’s 2004 Stock Incentive Plan in exchange for a significant portion of their outstanding stock options as of that date. Pursuant to the terms of the award, the shares shall vest in their entirety and become free from transfer restrictions on the one year anniversary of the grant date provided that (A) the Participant has been continuously employed by the Company during the period, (B) on or before the anniversary, the Company has filed on a timely basis any report required pursuant to Item 308 of Regulation S-K and (C) on the anniversary date the Company does not have any material weakness that has not been remedied to the satisfaction of the Audit Committee of the Company’s board of directors. In the event the

7


Table of Contents

Participant’s employment with the Company is terminated for any reason other than his death, his disability or a change of control of Bookham, all of the shares will be forfeited and the Participant shall have no further rights with respect to the shares. The Company recorded deferred compensation of approximately $750,000 representing the fair market value of the restricted shares on the date of the grant. The deferred compensation will be amortized over the term of the agreement as a charge to compensation expense, however, because there are performance metrics which prevent the shares from being vested over the term of the agreement, the grants will be fair valued at each reporting period and deferred compensation will be adjusted accordingly. The Company recorded an expense of $98,000 in the third quarter of fiscal 2005.

On September 22, 2004, options to purchase 1,730,950 shares of common stock of the Company were granted to employees under the Company’s 2004 Stock Incentive Plan at an exercise price of $6.73 per share. 50% of the options vest in accordance with the following performance based schedule: (i) as to 50% of these shares upon the Company achieving cash flow break-even (as defined as the point at which the Company generates earnings before interest, taxes, depreciation and amortization (excluding one-time items) that are greater than zero in any fiscal quarter prior to the termination of the option) and (ii) as to 50% of these shares upon the Company achieving profitability (as defined as the point at which the Company generates a profit before interest and taxes (excluding one-time items) that is greater than zero in any fiscal quarter prior to the termination of the option). In the event that either or both of the above-listed portions do not vest in full on or prior to September 22, 2009, such portion of the option shall become immediately vested. 50% of the options have a time based vesting schedule as follows: the options will vest (i) as to 25% of these shares on the first anniversary of the grant date and (ii) as to an additional 2.083% of these shares at the end of each successive month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

In December 2004, the FASB issued SFAS No. 123R which requires companies to recognize in their statement of operations all share-based payments to employees, including grants of employee stock options, based on their fair values. Accounting for share-based compensation transactions using the intrinsic method supplemented by pro forma disclosures will no longer be permissible. The new pronouncement will be effective for public entities no later than the beginning of the first fiscal year beginning after June 15, 2005. The Company will adopt the new pronouncement on July 3, 2005. The Company has not yet completed its analysis of the impact of adopting SFAS No. 123R and is therefore currently unable to quantify the effect it will have on its financial statements. However, the adoption of this new pronouncement will have a significant impact on the results of operations and net loss per share of the Company.

Note 4. Restructuring

In recent years, the Company has implemented a number of major restructuring plans as a result of the ongoing downturn in the optical components industry and to realize cost reduction benefits arising from the integration of acquired companies.

8


Table of Contents

The Company has two restructuring plans in place. The first restructuring plan was comprised of several activities prior to and following the Company’s acquisition of New Focus on March 8, 2004 (“the Acquisition Restructuring Plan”). This plan chiefly comprised closing the Company’s Ottawa facility and the transferring of its fabrication production into the Company’s Caswell facility, adding certain restructuring liabilities arising from the acquisition of New Focus in March 2004, and implementing other general cost reductions across the Company. This program is substantially complete except for the payment of certain severance and retention obligations and the continuing payments associated with the ongoing leases of non-occupied facilities.

The second plan (“the 2004 Restructuring Plan”), which was announced in May 2004, sought to reduce overhead by $10 million to $12 million per quarter on a cumulative value basis. In December 2004, the Company announced additional general overhead reduction measures designed to increase the quarterly overhead reduction to $16 million to $20 million per quarter. The Company anticipates the total cost of implementing these reductions to be in the range of $24 million to $30 million all of which the Company expects will require the expenditure of cash. The key component of the 2004 Restructuring Plan is the transfer of the majority of the assembly and test operations from the Company’s facility in Paignton, UK to the Company’s facility in Shenzhen, China to take advantage of the substantially reduced cost base in China. The Shenzhen facility was acquired as part of the Company’s acquisition of New Focus and the Company is actively staffing the facility and transferring production of the first product lines into the new facility. In addition, the 2004 Restructuring Plan calls for the discontinuation of the Company’s GaAs fabrication product line as well as other general cost reductions throughout the Company. As a result of the Company changing its domicile from the United Kingdom to the United States, during the second quarter of fiscal 2005, the Company closed its headquarters office in Abingdon, UK and transferred its headquarters to San Jose, California and relocated its UK Corporate staff to its facility in Caswell, UK. The Company expects these programs to reduce its overhead expenses in the coming quarters but, due to the complexity and time involved to transfer some product lines to China and the need to keep UK operations open to meet current product demand, a portion of the anticipated savings is expected to take 12 to 15 months to achieve.

Included in each restructuring plan were costs related to severance pay, the write-down of the carrying value of equipment used by terminated product lines, office closures and the termination of certain office leases. Facility closing charges are recognized under the restructuring programs for the expected remaining future cash outlays associated with remaining lease liabilities, lease termination payments and expected restoration costs in connection with plans to reduce the number of leased facilities. The remaining liability is expected to be paid over the remaining lease terms and is reflected net of expected sublease income. Additional charges may be required in the future if the expected sublease income is not realized. In the three months ended April 2, 2005, $3.7 million of restructuring charges were in the Company’s Optics segment and $0.1 million were in the Company’s Research and Defense segment (see Note 12 for additional segment information). All restructuring charges were incurred within the Company’s Optics segment in the previous quarters.

9


Table of Contents

The following tables summarize the activity on the restructuring plans for the three and nine months ended April 2, 2005 (in thousands):